articleTop 1% cited
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
European Urology · 2009 · Vol. 57(1) · pp. 123–131
Claus G. Roehrborn✉(The University of Texas Southwestern Medical Center)Paul Siami(Deaconess Clinic)Jack Barkin(University of Toronto)Ronaldo Damião(Universidade do Estado do Rio de Janeiro)Kim Major‐Walker(Research Triangle Park Foundation)Indrani Nandy(GlaxoSmithKline (United States))Betsy Morrill(Research Triangle Park Foundation)R. Paul Gagnier(Research Triangle Park Foundation)Francesco Montorsi(Vita-Salute San Raffaele University)
Urinary Bladder and Prostate ResearchProstate Cancer Diagnosis and TreatmentPelvic floor disorders treatmentsMedicineTamsulosinDutasterideTolerabilityUrologyCombination therapyLower urinary tract symptomsProstateInternational Prostate Symptom ScoreUrinary retention
MeSH terms
DutasterideTamsulosinAdrenergic alpha-AntagonistsAgedAzasteroidsBrazilDouble-Blind MethodDrug Therapy, CombinationEnzyme InhibitorsHumansItalyMaleMiddle AgedNorth AmericaProstatic Hyperplasia
Citations
778
FWCI
42.33
field-weighted impact
References
14
Percentile
100%
vs. same field & year
Citations per year
Cited by
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta‐analysis
British Journal of Clinical Pharmacology · 2016 · 492 citations
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
European Urology · 2013 · 1,233 citations
References
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.